Skip to main content
. 2022 Jun 1;23(11):6206. doi: 10.3390/ijms23116206

Figure 10.

Figure 10

(A) Chemical structure of the non-canonical MG compound asukamycin; (B) asukamycin-mediated covalently engaged TP53/p53-UBR7 formation models.